Covetrus Inc. (CVET)
NASDAQ: CVET
· Real-Time Price · USD
20.99
0.00 (0.00%)
At close: Oct 12, 2022, 10:00 PM
Covetrus Revenue Breakdown
| Period Ending | Sep 30, 2019 | Jun 30, 2019 |
|---|---|---|
| APAC and Emerging Markets Revenue | 94M | 90M |
| APAC and Emerging Markets Revenue Growth | +4.44% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific And Emerging Markets Revenue | 109M | 112M | 119M | 116M | 114M | 112M | 114M | 108M | 85M | 95M |
| Asia Pacific And Emerging Markets Revenue Growth | -2.68% | -5.88% | +2.59% | +1.75% | +1.79% | -1.75% | +5.56% | +27.06% | -10.53% | n/a |
| Europe Segment Revenue | 325M | 340M | 332M | 353M | 366M | 361M | 405M | 403M | 342M | 422M |
| Europe Segment Revenue Growth | -4.41% | +2.41% | -5.95% | -3.55% | +1.39% | -10.86% | +0.50% | +17.84% | -18.96% | n/a |
| North America Segment Revenue | 783M | 696M | 674M | 697M | 713M | 635M | 606M | 618M | 602M | 550M |
| North America Segment Revenue Growth | +12.50% | +3.26% | -3.30% | -2.24% | +12.28% | +4.79% | -1.94% | +2.66% | +9.45% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 29, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 225M | 219M | 219M | 220M | 229M | 213M | 225M | 224M | 196M | 222M | 198M | 216M | 205M | 189M | 125.11M | 132M | 139M | 143M | 133.74M |
| Selling, General, and Administrative Revenue Growth | +2.74% | 0.00% | -0.45% | -3.93% | +7.51% | -5.33% | +0.45% | +14.29% | -11.71% | +12.12% | -8.33% | +5.37% | +8.47% | +51.07% | -5.22% | -5.04% | -2.80% | +6.93% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |